Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0621 USD | +16.55% |
|
+3.50% | +53.33% |
05-15 | Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Nu-Med Plus, Inc. Announces CEO Changes | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 3.38M 267M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 26.8K 2.12M | Net Debt 2023 | 93.19K 7.37M | EV / Sales 2023 | - |
P/E ratio 2022 |
-10.1
x | P/E ratio 2023 |
-26.3
x | Employees | 2 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.96% |
1 day | +16.55% | ||
1 week | +3.50% | ||
Current month | +24.20% | ||
1 month | +0.16% | ||
3 months | +38.00% | ||
6 months | +85.93% | ||
Current year | +53.33% |
![Extreme 0.0401](/images/extremecours_fleche.png)
![Extreme 0.0306](/images/extremecours_fleche.png)
![Extreme 0.02](/images/extremecours_fleche.png)
![Extreme 0.0116](/images/extremecours_fleche.png)
![Extreme 0.009](/images/extremecours_fleche.png)
![Extreme 0.009](/images/extremecours_fleche.png)
![Extreme 0.009](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Bill Hayde
CHM | Chairman | 59 | 11/09/22 |
Keith Merrell
DFI | Director of Finance/CFO | 78 | 31/07/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Merrell
DFI | Director of Finance/CFO | 78 | 31/07/15 |
Jeffrey Robins
CEO | Chief Executive Officer | 75 | - |
Bill Hayde
CHM | Chairman | 59 | 11/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
21/06/24 | 0.0621 | +16.55% | 500 |
20/06/24 | 0.0533 | 0.00% | 116,061 |
18/06/24 | 0.0533 | -0.11% | 19,063 |
17/06/24 | 0.0534 | -11.07% | 17,126 |
Delayed Quote OTC Markets, June 21, 2024 at 08:57 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+53.33% | 5.19M | |
-3.95% | 184B | |
-0.90% | 109B | |
-2.27% | 68.87B | |
+15.24% | 46.61B | |
-6.00% | 46.39B | |
+5.36% | 40.74B | |
+20.65% | 31.26B | |
+11.60% | 24B | |
-5.50% | 24.24B |
- Stock Market
- Equities
- NUMD Stock